עם ישראל חי!
פתיחת תפריט נגישות
גישה מהירה לדף הבית

שעונית - Passiflora incarnata

עודכן בתאריך 16/06/2022

Passion flower


משפחה בוטנית: שעוניתיים – Passifloraceae

חלק הצמח | איכויות | רכיבים פעילים | התוויות | מינונים | רגישות | תופעות לוואי | 

מינון יתר | אזהרות | התוויות נגד | רעילות | אינטראקציות | הריון | הנקה

 

שמו הבוטני של הצמח נקרא על שם תשוקתו וסבלו של ישו, עקב דמיון התפרחת לכלי התשוקה השונים ששימשו לצליבתו (כתר הקוצים, חנית, מסמרים).

שעונית הינה צמח רב-שנתי מטפס. מוצאו במזרח ומרכז ארה״ב. 

שעונית מותרת לשיווק בישראל.


חלק הצמח בשימוש

נוף הצמח.

 

איכויות

טמפרטורה: ניטראלי, קריר.

לחות: יבש.

טעם: מעט מריר.

 

רכיבים פעילים עיקריים

פלבונואידים (vitexin, isovitexin, apigenin, luteolin, kaempferol, quercetin, rutin), גליקוזידים ציאנוגנטיים (gynocardin).

*כמו כן, שעונית עלולה להכיל כמויות מזעריות של אלקלואידים אינדולים (harman, harmol, harmine). חומרים אלה אינם תורמים לפעילות הצמח, אך עלולים לגרום לרעילות.

 

התוויות

חרדה, הפרעות שינה (אינסומניה), לחץ דם גבוה, תסמונת המעי הרגיש (IBS), כאב.

 

מינונים

תמצית נוזלית בריכוז 1:3, 45% אלכוהול – 5-25 מ״ל ביום.

תמצית יבשה – תלוי בריכוז התמצית; מינון השווה ל- 1.5-6 גרם צמח ביום.

חליטה – 4-15 גרם ביום.

בפורמולה – 20-30%.

 

רגישות

קיימים דיווחים נדירים על   למידע השלם למנויים

באחד המקרים, הצמח נמצא כ למידע השלם למנויים

 

תופעות לוואי

סקירת מחקרים קליניים שנערכה בשנת 2013 קבעה כי לשעונית פרופיל בטיחות גבוה(4).

מקרה בודד של   למידע השלם למנויים

 

מינון יתר

מינון יתר של   למידע השלם למנויים

 

אזהרות וצעדי מנע

מהיותו מעכב עצבי, השימוש בשעונית אסור לאנשים הסובלים מ   למידע השלם למנויים

 

התוויות נגד

לא ידועות התוויות נגד לשימוש בשעונית(7), למעט   למידע השלם למנויים

 

רעילות

במבחן רעילות תת-אקוטית שנערך בחולדות וכלל נטילה פומית של   למידע השלם למנויים

הזרקה בטנית של תמצית שעונית לעכברים במינון   למידע השלם למנויים

 

תגובות הדדיות עם תרופות / צמחי מרפא / תוספי תזונה

 

תרופות משרות שינה - למידע השלם למנויים

 

תרופות הרגעה - 

 

ושיכוך כאב (אופיאטים) - למידע השלם למנויים

 

הרדמה של עמוד השדרה (spinal anesthesia)   למידע השלם למנויים

 

הרדמה של חלל הפה - למידע השלם למנויים 

 

תרופות מרפות שרירים - למידע השלם למנויים 

 

תרופות נוגדות קרישה  למידע השלם למנויים 

 

מסדרי קצב לב - למידע השלם למנויים 

 

נוגדי דלקת NSAID's - למידע השלם למנויים 

 

נוגדי פרכוסים - למידע השלם למנויים 

 

נוגדי דכאון SSRI - למידע השלם למנויים 

 

אנטי-היסטמינים - למידע השלם למנויים 

 

הורדת רמות סוכר - למידע השלם למנויים 

 

נוגדי שיעול - למידע השלם למנויים 

 

Valeriana officinalis - למידע השלם למנויים 

 

Humulus lupulus - למידע השלם למנויים 

 

Hypericum perforatum - למידע השלם למנויים 

 

הריון

שימוש מוגבל בנשים אינו מעיד על כל נזק או רעילות עקב שימוש בתקופה זו(7). 

במחקרים שנערכו בחולדות, נטילת תמצית שעונית   למידע השלם למנויים

עם זאת, מקורות שונים(15,35-37) טוענים   למידע השלם למנויים

 

 

הנקה

שעונית אפשרית לשימוש בהנקה(7,39).

 

 

מקורות

  1. Smith GW, Chalmers TM, Nuki G. Vasculitis associated with herbal preparation containing Passiflora extract. British Journal of Rheumatology, 1993, 32:87–88. https://www.ncbi.nlm.nih.gov/pubmed/8422575
  2. Giavina-Bianchi PF et al. Occupational respiratory allergic disease induced by Passiflora alata and Rhamnus purshiana. Annals of Allergy, Asthma, and Immunology, 1997, 79:449–454. https://www.ncbi.nlm.nih.gov/pubmed/9396980
  3. Echechipia S, Garcia BE, Alvarez MJ, et al. Passiflora hyper-sensitivity in a latex allergic patient: Cross reactivity study. Allergy 51(Suppl 31):49, 1996.
  4. Miroddi M, Calapai G, Navarra M, Minciullo PL, Gangemi S. Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials. J Ethnopharmacol. 2013 Dec 12;150(3):791-804. Epub 2013 Oct 17. https://www.ncbi.nlm.nih.gov/pubmed/24140586.
  5. Fisher AA, Purcell P, Le Couteur DG. Toxicity of Passiflora incarnata L. Journal of Toxicology. Clinical Toxicology, 2000, 38:63–66. https://www.ncbi.nlm.nih.gov/pubmed/10696928
  6. Lamchouri F, Settaf A, Cherrah Y, El Hamidi M, Tligui N, Lyoussi B, Hassar M. Experimental toxicity of Peganum harmala seeds. Ann Pharm Fr. 2002 Mar;60(2):123-9. https://www.ncbi.nlm.nih.gov/pubmed/11976557
  7. Mills. S, Bone K, The Essential Guide to Herbal Safety. Churchill Livingstone, 2005. https://www.elsevier.com/books/the-essential-guide-to-herbal-safety/mills/978-0-443-07171-3.
  8. Wagner H, Bladt S. Plant drug analysis – a thin-layer chromatography atlas, 2nd ed. Berlin, Springer, 1996. https://www.springer.com/gb/book/9783642005732
  9. Blaschek W, Ebel S, Hackenthal E, et al. HagerROM 2002: Hagers Handbuch der Drogen und Arzneistoffe. Heidelberg: Springer; 2002. https://www.springer.com/de/book/9783540282358.
  10. Hänsel R et al., eds. Hagers Handbuch der pharmazeutischen Praxis. Bd 6, Drogen P–Z, 5th ed. [Hager’s handbook of pharmaceutical practice. Vol. 6, Drugs P–Z, 5th ed.] Berlin, Springer, 1994. https://www.springer.com/us/book/9783642633904.
  11. Bisset NG. Herbal drugs and phytopharmaceuticals. Boca Raton, FL, CRC Press, 1994. https://www.scirp.org/(S(351jmbntvnsjt1aadkposzje))/reference/ReferencesPapers.aspx?ReferenceID=1332106.
  12. Farnsworth NR, ed. NAPRALERT database. Chicago, IL, University of Illinois at Chicago, 9 February 2001 production (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network (STN) of Chemical Abstracts Services). https://pubmed.ncbi.nlm.nih.gov/18258647/
  13. Bruneton J. Pharmacognosy, phytochemistry, medicinal plants. Paris, Lavoisier Publishing, 1995.
  14. Meier B. Passiflora incarnata L. – Passionsblume. [Passiflora incarnata L. – passion flower.] Zeitschrift für Phytotherapie, 1995, 16:115–126. https://www.researchgate.net/publication/285528693
  15. Brinker F. Herb Contraindications and Drug Interactions, 4th ed. Sandy (OR): Eclectic Medical Publications; 2010. https://www.eclecticherb.com/herb-contraindications-drug-interactions
  16. Aoyagi N, Kimura R, Murata T. Studies on Passiflora incarnata dry extract. I. Isolation of maltol and pharmacological action of maltol and ethyl maltol. Chem. Pharm. Bull., 22:1008-1013, 1974. https://www.ncbi.nlm.nih.gov/pubmed/4421168
  17. Speroni E, Minghetti A. Neuropharmacological activity of extracts. Planta Med., 54:488-491, 1988. https://www.ncbi.nlm.nih.gov/pubmed/3212072
  18. Speroni E, Billi R, Mercati V, et al. Sedative effects of crude extract of Passiflora incarnata after oral administration. Phytother. Res., 10:S92-S94, 1996. https://www.researchgate.net/publication/279601896
  19. Speroni E, Billi R, Perellino NC, et al. Role of chrysin in the sedative effects of Passiflora incarnata L. Phytother. Res., 10:S98-S100, 1996. https://www.researchgate.net/publication/279601897.
  20. Soulimani R, Younos C, Jarmouni S, et al. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J. Ethnopharm., 57:11-20, 1997. https://www.ncbi.nlm.nih.gov/pubmed/9234160
  21. Sopranzi N et al. Parametri biologici ed electroencefalografici nel ratto correlati a Passiflora incarnata L. [Biological and electroencephalographic parameters in rats associated with Passiflora incarnata L.] Clinica Terapia, 1990, 132:329–333. https://www.ncbi.nlm.nih.gov/pubmed/2139836.
  22. duplicate of 16
  23. Capasso A, Sorrentino L. Pharmacological studies on the sedative and hypnotic effect of kava kava and Passiflora extracts combination. Phytomed., 12:39-45, 2005. https://www.ncbi.nlm.nih.gov/pubmed/15693706
  24. Dhawan K, Kumar S, Sharma A. Evaluation of central nervous system effects of Passiflora incarnata in experimental animals. Pharm. Biol.,41(2):87-91, 2003. https://www.tandfonline.com/doi/pdf/10.1076/phbi.41.2.87.14241
  25. Carrasco M C, Vallejo JR, Pardo-de-Santayana M, et al. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytotherapy Research. 2009;23(12):1795–1796. https://www.ncbi.nlm.nih.gov/pubmed/19441067
  26. Wahling C, Wegener T, Tschaikin M. Triple herbal combination: An effective alternative to benzodiazepines. Zeitsch. Phytother. 30:69-72, 2009. http://accurateclinic.com/wp-content/uploads/2016/02/Herbal-triple-combination-An-effective-alternative-to-benzodiazepines.-CAB-Direct.pdf.
  27. Akhondzadeh S, Kashani L, Mobaseri M, et al. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J. Clin. Pharm. Ther., 26:369-373, 2001. https://www.ncbi.nlm.nih.gov/pubmed/11679027
  28. Dhawan K, Dhawan S, Chhabra S. Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiey of Passiflor incarnata Linneaus: a non-habit forming anxiolytic. J. Pharm. Pharmaceut. Sci., 6(2):215-222, 2003. https://www.ncbi.nlm.nih.gov/pubmed/12935433
  29. Dhawan K, Kumar S, Sharma A. Reversal of morphine tolerance and dependence by Passiflora incarnata – a traditional medicine to combat morphine addiction. Pharmaceut. Bio., 40(8):576-580, 2002. https://www.tandfonline.com/doi/abs/10.1076/phbi.40.8.576.14660.
  30. Dhawan K, Kumar S, Sharma A. Suppression of alcohol-cessation-oriented hyper-anxiety by the benzoflavone moiety of Passiflora incarnata Linnaeaus in mice. J. Ethnopharm., 81:239-244, 2002. https://www.ncbi.nlm.nih.gov/pubmed/12065157
  31. Dhawan K, Kumar S, Sharma A. Reversal of cannabinoids (9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction. J. Pharm. Pharmacol., 54:875-881, 2002. https://www.ncbi.nlm.nih.gov/pubmed/12079005.
  32. Dhawan K, Kumar S, Sharma A. Nicotine revcersal effects of the benzoflavone moiety from Passiflora incarnata Linneaus in mice. Addict. Biol., 7:435-441, 2002. https://www.ncbi.nlm.nih.gov/pubmed/14578021.
  33. Aslanargun P, Cuvas O, Dikmen B, Aslan E, Yuksel MU. Passiflora incarnata Linneaus as an anxiolytic before spinal anesthesia. J Anesth. 2012 Feb;26(1):39-44. Epub 2011 Nov 3. https://www.ncbi.nlm.nih.gov/pubmed/22048283
  34. Argento A, Tiraferri E, Marzaloni M. Oral anticoagulants and medicinal plants. An emerging interaction. Ann. Ital. Med. Int. 2000; 15: pp. 139-143. https://www.ncbi.nlm.nih.gov/pubmed/10920504
  35. Mouly S, Lloret-Linares C, Sellier PO,et al., Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John's Wort? Pharmacol Res. 2017 Apr;118:82-92. https://www.ncbi.nlm.nih.gov/pubmed/27693910
  36. Leite PM, Martins MAP, Castilho RO., Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy, Biomed. Pharmacother. 83 (2016) 14–21. https://www.ncbi.nlm.nih.gov/pubmed/27470545
  37. Sato AC, Andrade SA, Brito MV, et al., Effects of compounds from Passiflora edulis Sims f. flavicarpa juice on blood coagulation and on proteolytic enzymes. Protein Peptide Lett. 2012; 19: pp. 501-508. https://www.ncbi.nlm.nih.gov/pubmed/22486645
  38. Schardein JL: Chemically induced birth defects, ed 2, New York, 1993, Markel Dekker, pp 800-822. https://www.crcpress.com/Chemically-Induced-Birth-Defects/Schardein/p/book/9780824702656.
  39. Hirakara T, Suzuki T, Sano Y, et al: High protein intake is associated with low prevalence of frailty among old Japanese women: a multicenter cross-sectional study. Kiso To Rinsho 15:3431-3451, 1981. https://www.ncbi.nlm.nih.gov/pubmed/24350714
  40. WHO. Herba Passiflorae. WHO Monographs on Selected Medicinal Plants. 3 vol. Geneva: World Health Organization; 2007:257-267. http://apps.who.int/medicinedocs/en/d/Js2200e/.
  41. Brinker F. The Toxicology of Botanical Medicines, 3rd ed. Eclectic Medical Pub., Sandy, Ore., 2000. https://www.eclecticherb.com/the-toxicology-of-botanical-medicines/.
  42. Farnsworth NR, Bingel AS, Cordell GA, et al. Potential value of plants as sources of new antifertility agents I. J. Pharm. Sci., 64:535-598, 1975. https://www.ncbi.nlm.nih.gov/pubmed/167146
  43. Ruggy GH, Smith CS. A pharmacological study of the active principle of Passiflora incarnata. Journal of the American Pharmaceutical Association. Scientific Edition, 1940, 29:245. https://onlinelibrary.wiley.com/doi/abs/10.1002/jps.3030290602
  44. McGuffin M, Hobbs C, Upton R, Goldberg A (eds). American Herbal Products Association’s Botanical Safety Handbook. Boca Raton, FL: CRC Press, 1997. https://www.crcpress.com/American-Herbal-Products-Associations-Botanical-Safety-Handbook/Gardner-McGuffin/p/book/9781466516946.
  45. Schäfer AM, Gilgen PM, Spirgi C, et al. Constituents of Passiflora incarnata, but Not of Valeriana officinalis, Interact with the Organic Anion Transporting Polypeptides (OATP)2B1 and OATP1A2. Planta Med. 2022 Feb;88(2):152-162. https://pubmed.ncbi.nlm.nih.gov/33511622/
  46. Ulbricht C, Basch E, Boon H, et al. An evidence-based systematic review of passion flower (Passiflora incarnata L.) by the Natural Standard Research Collaboration. J Diet Suppl. 2008;5(3):310-40.  https://pubmed.ncbi.nlm.nih.gov/22432466/
  47. Janda K, Wojtkowska K, Jakubczyk K, et al. Passiflora incarnata in Neuropsychiatric Disorders-A Systematic Review. Nutrients. 2020 Dec 19;12(12):3894.  https://pubmed.ncbi.nlm.nih.gov/33352740/
  48. Araújo JO, Bergamaschi CC, Lopes LC, et al. Effectiveness and safety of oral sedation in adult patients undergoing dental procedures: a systematic review. BMJ Open. 2021 Jan 25;11(1):e043363. https://pubmed.ncbi.nlm.nih.gov/33495257/
  49. Sarris J. Herbal medicines in the treatment of psychiatric disorders: 10-year updated review. Phytother Res. 2018 Jul;32(7):1147-1162.  https://pubmed.ncbi.nlm.nih.gov/29575228/
  50. Sarris J. Herbal medicines in the treatment of psychiatric disorders: a systematic review. Phytother Res. 2007 Aug;21(8):703-16. https://pubmed.ncbi.nlm.nih.gov/17562566/
  51. Brown E, Hurd NS, McCall S, Ceremuga TE. Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J. 2007 Oct;75(5):333-7. https://pubmed.ncbi.nlm.nih.gov/17966676/
  52. Akhondzadeh S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001 Oct;26(5):363-7. https://pubmed.ncbi.nlm.nih.gov/11679026/
  53. Appel K, Rose T, Fiebich B, et al. Modulation of the γ-aminobutyric acid (GABA) system by Passiflora incarnata L. Phytother Res. 2011 Jun;25(6):838-43. https://pubmed.ncbi.nlm.nih.gov/21089181/
  54. Nassiri-Asl M, Zamansoltani F, Shariati-Rad S. Possible role of GABAA-benzodiazepine receptor in anticonvulsant effects of Pasipay in rats. Zhong Xi Yi Jie He Xue Bao. 2008 Nov;6(11):1170-3. https://pubmed.ncbi.nlm.nih.gov/18990344/
  55. Kaviani N, Tavakoli M, Tabanmehr M, Havaei R. The efficacy of passiflora incarnata linnaeus in reducing dental anxiety in patients undergoing periodontal treatment. J Dent (Shiraz). 2013 Jun;14(2):68-72. https://pubmed.ncbi.nlm.nih.gov/24724122/
  56. Movafegh A, Alizadeh R, Hajimohamadi F, et al. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study. Anesth Analg. 2008 Jun;106(6):1728-32. https://pubmed.ncbi.nlm.nih.gov/18499602/
  57. Ngan A, Conduit R. A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality. Phytother Res. 2011 Aug;25(8):1153-9. https://pubmed.ncbi.nlm.nih.gov/21294203/
  58. Lee J, Jung HY, Lee SI, Choi JH, Kim SG. Effects of Passiflora incarnata Linnaeus on polysomnographic sleep parameters in subjects with insomnia disorder: a double-blind randomized placebo-controlled study. Int Clin Psychopharmacol. 2020 Jan;35(1):29-35. https://pubmed.ncbi.nlm.nih.gov/31714321/
  59. Dhawan K, Kumar S, Sharma A. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia. 2001 Dec;72(8):922-6. https://pubmed.ncbi.nlm.nih.gov/11731118/
  60. Dhawan K, Kumar S, Sharma A. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol. 2001 Dec;78(2-3):165-70. https://pubmed.ncbi.nlm.nih.gov/11694362/
  61. Elsas SM, Rossi DJ, Raber J, et al. Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine. 2010 Oct;17(12):940-9. https://pubmed.ncbi.nlm.nih.gov/20382514/
  62. Grundmann O, Wang J, McGregor GP, Butterweck V. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med. 2008 Dec;74(15):1769-73. https://pubmed.ncbi.nlm.nih.gov/19006051/
  63. Ebrahimie M, Bahmani M, Shirzad H, Rafieian-Kopaei M, Saki K. A Review Study on the Effect of Iranian Herbal Medicines on Opioid Withdrawal Syndrome. J Evid Based Complementary Altern Med. 2015 Oct;20(4):302-9. http://pubmed.ncbi.nlm.nih.gov/25818661/
  64. da Cunha RS, Amorim KS, Gercina AC, et al. Herbal medicines as anxiolytics prior to third molar surgical extraction. A randomized controlled clinical trial. Clin Oral Investig Mar;25(3):1579-1586.2021 https://pubmed.ncbi.nlm.nih.gov/32951121
  65. Dantas LP, de Oliveira-Ribeiro A, de Almeida-Souza LM, Groppo FC. Effects of passiflora incarnata and midazolam for control of anxiety in patients undergoing dental extraction. Med Oral Patol Oral Cir Bucal. 2017 Jan 1;22(1): e95-e101. https://pubmed.ncbi.nlm.nih.gov/27918731
  66. Kerachian N, Alaee H, Gharavi-Naini M, Pilevarian A, Moghimi A. Effects of alcoholic extract of Avena sativa, Hypericum perforatum, Passiflora incarnata and Lavandula officinalis on symptoms of morphine withdrawal syndrome in rats. Physiol Pharmacol. 2007; 10 (4) :313-321 .  http://ppj.phypha.ir/article-1-290-en.html
  67. Dos Reis Izolan L, da Silva DM, Oliveira HBL, et al. Sintocalmy, a Passiflora incarnata Based Herbal, Attenuates Morphine Withdrawal in Mice. Neurochem Res. 2021 May;46(5):1092-1100. https://pubmed.ncbi.nlm.nih.gov/33544325/
  68. Kim M, Lim HS, Lee HH, Kim TH. Role Identification of Passiflora Incarnata Linnaeus: A Mini Review. J Menopausal Med. 2017 Dec;23(3):156-159. https://pubmed.ncbi.nlm.nih.gov/29354614/
  69. da Fonseca LR, Rodrigues RA, Ramos AS, et al. Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential. ScientificWorldJournal. 2020 Jul 20;2020:6598434. https://pubmed.ncbi.nlm.nih.gov/32765195/
  70. Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinicalmevidence. CNS Drugs. 2013 Apr;27(4):301-19. https://pubmed.ncbi.nlm.nih.gov/23653088/
  71. Wheatley D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol. 2005 Jul;19(4):414-21. https://pubmed.ncbi.nlm.nih.gov/15982998/
  72. Weeks BS. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med Sci Monit. 2009 Nov;15(11):RA256-62. https://pubmed.ncbi.nlm.nih.gov/19865069/
  73. Ernst E. Herbal remedies for anxiety - a systematic review of controlled clinical trials. Phytomedicine. 2006 Feb;13(3):205-8. https://pubmed.ncbi.nlm.nih.gov/16428031/
  74. Kinrys G, Coleman E, Rothstein E. Natural remedies for anxiety disorders: potential use and clinical applications. Depress Anxiety. 2009;26(3):259-65. https://pubmed.ncbi.nlm.nih.gov/19123457/
  75. Baek JH, Nierenberg AA, Kinrys G. Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder. Aust N Z J Psychiatry. 2014 Aug;48(8):705-15. https://pubmed.ncbi.nlm.nih.gov/24947278/
  76. Dhawan K, Kumar R, Kumar S, Sharma A. Correct Identification of Passiflora incarnata Linn., a Promising Herbal Anxiolytic and Sedative. J Med Food. 2001 Autumn;4(3):137-144. https://pubmed.ncbi.nlm.nih.gov/12639407/
  77. Bourin M, Bougerol T, Guitton B, Broutin E. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol. 1997;11(2):127-32. https://pubmed.ncbi.nlm.nih.gov/9107558/
  78. Lakhan SE, Vieira KF. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review. Nutr J. 2010;9:42. https://pubmed.ncbi.nlm.nih.gov/20929532/
  79. duplicate of 5
  80. Modabbernia A, Akhondzadeh S. Saffron, passionflower, valerian and sage for mental health. Psychiatr Clin North Am. 2013 Mar;36(1):85-91. https://pubmed.ncbi.nlm.nih.gov/23538079/
  81. Dhawan K, Dhawan S, Sharma A. Passiflora: a review update. J Ethnopharmacol. 2004 Sep;94(1):1-23. 
  82. Miyasaka LS, Atallah AN, Soares BG. Passiflora for anxiety disorder. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004518.  https://pubmed.ncbi.nlm.nih.gov/17253512/
  83. Mori A, Hasegawa K, Murasaki M, Yamauchi T, et al. Clinical Evaluation of Passiflamin (passiflora extract) on neurosis ‐ multicenter double-blind study in comparison with Mexazolam. Clinical Evaluation 1993;21:383‐440.
  84. Rodriguez-Fragoso L, Reyes-Esparza J, Burchiel SW, Herrera-Ruiz D, Torres E. Risks and benefits of commonly used herbal medicines in Mexico. Toxicol Appl Pharmacol. 2008 Feb 15;227(1):125-35. https://pubmed.ncbi.nlm.nih.gov/18037151/
  85. Christoffoli MT, Bachesk AB, Farah GJ, Ferreira GZ. Assessment of Passiflora incarnata L for conscious sedation of patients during the extraction of mandibular third molars: randomized, split-mouth, double-blind, crossover study. Quintessence Int. 2021 Oct 19;52(10):868-878. https://pubmed.ncbi.nlm.nih.gov/34076379/
  86. Cicero A. F. G., Colletti A. Nutraceuticals Active on Central Nervous System. Cham, Switzerland: Springer International Publishing AG; 2018. Handbook of Nutraceuticals for Chemical Use; pp. 1–23. 
  87. Zhang W, Yan Y, Wu Y, et al. Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis. Pharmacol Res. 2022 Apr 1;179:106204. https://pubmed.ncbi.nlm.nih.gov/35378276/
  88. Aman U, Subhan F, Shahid M, et al. Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms. BMC Complement Altern Med. 2016 Feb 24;16:77.  https://pubmed.ncbi.nlm.nih.gov/26912265/
  89. Salgueiro JB, Ardenghi P, Dias M, et al. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav. 1997;58(4):887–91. https://pubmed.ncbi.nlm.nih.gov/9408191/
  90. Singh B, Singh D, Goel RK. Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression. J Ethnopharmacol. 2012 Jan 6;139(1):273-9. https://pubmed.ncbi.nlm.nih.gov/22107833/
  91. duplicate of 61
  92. Goel RK, Gawande D, Lagunin A, et al. Revealing Medicinal Plants That Are Useful for the Comprehensive Management of Epilepsy and Associated Comorbidities through In Silico Mining of Their Phytochemical Diversity. Planta Med. 2015 Apr;81(6):495-506. https://pubmed.ncbi.nlm.nih.gov/25856437/
  93. Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J. Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance. Phytother Res. 2018 May;32(5):865-891. https://pubmed.ncbi.nlm.nih.gov/29464801/
  94. Nojoumi M, Ghaeli P, Salimi S, et al. Effects of Passion Flower Extract, as an Add-On Treatment to Sertraline, on Reaction Time in Patients ‎with Generalized Anxiety Disorder: A Double-Blind Placebo-Controlled Study. Iran J Psychiatry. 2016 Jul;11(3):191-197. https://pubmed.ncbi.nlm.nih.gov/27928252/
  95. Dhawan K, Sharma A. Antitussive activity of the methanol extract of Passiflora incarnata leaves. Fitoterapia. 2002 Aug;73(5):397-9.  https://pubmed.ncbi.nlm.nih.gov/12165335/
  96. Gupta RK, Kumar D, Chaudhary AK, Maithani M, Singh R. Antidiabetic activity of Passiflora incarnata Linn. in streptozotocin-induced diabetes in mice. J Ethnopharmacol. 2012 Feb 15;139(3):801-6.  https://pubmed.ncbi.nlm.nih.gov/22212504/
  97. Maroo N, Hazra A, Das T. Efficacy and safety of a polyherbal sedative hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian J Pharmacol. 2013 Jan-Feb;45(1):34-9. https://pubmed.ncbi.nlm.nih.gov/23543804/
  98. Trompetter I, Krick B, Weiss G. Herbal triplet in treatment of nervous agitation in children. Wien Med Wochenschr. 2013 Feb;163(3-4):52-7. https://pubmed.ncbi.nlm.nih.gov/23179673/
  99. Fiebich BL, Knörle R, Appel K, Kammler T, Weiss G. Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): in vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models. Fitoterapia. 2011. Apr;82(3):474-80. https://pubmed.ncbi.nlm.nih.gov/21185920/

דוגמא למונוגרף מלא

לרכישת מנוי  |  כניסת מנויים

בחזרה לדף הראשי של האינדקס

חזרה לתחילת העמוד

חזרה לעמוד הקודם